[Practical control methods for the dose individualization of anticancer drugs].
Most anticancer drugs are characterized by a narrow therapeutic index, wide inter-patient variability of pharmacokinetic parameters and high toxicity. The need for dose individualization of anticancer drugs is now well accepted. The strategies that can be employed for optimizing dosage regimen were reviewed. The aim of this paper was to provide an insight into the feasibility of these techniques in anticancer chemotherapy and their application at all stages of clinical trials and practice.